TCR2 Therapeutics to Present at the 2017 UBS Global Healthcare Conference

Tuesday, May 16, 2017 General News
Email Print This Page Comment
Font : A-A+

CAMBRIDGE, Mass., May 16, 2017 /PRNewswire/ -- TCR2 Therapeutics Inc. announced today that its Chief Executive

Officer, Garry E. Menzel, Ph.D., will present a corporate overview at the UBS Global Healthcare Conference on Tuesday, May 23, 2017 at 9:30 AM Eastern Time. The
event will be held in New York at the Grand Hyatt New York.

About TCR2 Therapeutics TCR2 Therapeutics is an immuno-oncology company that has pioneered a novel class of T cell therapies that utilize the full signaling power of complete T cell receptors (TCR). TCR2 has developed a unique proprietary TRuC™ platform which can reprogram the natural TCR complex to recognize specific antigens found on tumors where they elicit rapid killing of cancer cells. The company has demonstrated superior activity against both hematological and solid tumor targets in preclinical models compared to CAR-T and believes its TRuC™-reprogrammed T cells will serve as a backbone for solid tumor therapies. TCR2 was founded in 2015 by Dr. Patrick Baeuerle and backed with a $44.5M Series A financing led by MPM Capital and F2 Ventures. It has since assembled a world-class team of immunotherapy experts and entrepreneurs located in the heart of Kendall Square in Cambridge, MA. For more information, please visit www.tcr2.com.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tcr2-therapeutics-to-present-at-the-2017-ubs-global-healthcare-conference-300457998.html

SOURCE TCR2 Therapeutics



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook